AstraZeneca is no longer pursuing plans for a 450 million pound ($558.32 million) vaccine manufacturing plant in Speke, Liverpool, a company spokesperson said on Friday.

NLS Pharmaceutics (NLSP) and Kadimastem, a clinical-stage cell therapy company specializing in the treatment of neurodegenerative diseases and ...

Oil company Shell says is still mulling moving its stock market listing from London to New York but that it wasn't a “live ...

Swifty Global is a global online sports and casino technologies company with a track record of revenue growth and profitability. Swifty Global’s strengths and growth strategies are expected to ...

British "industrial aristocracy" Dowlais joins exodus from London stock market - Dowlais traces its roots back to the ...

Japan's Sumitomo Mitsui Financial Group said third-quarter net profit surged 54% on a boost in interest income, putting it on ...

Plus, takeover talks between Switzerland’s SGS and France’s Bureau Veritas fall apart, and junior lawyers pivot to private equity ...

The battle over American manufacturing icon U.S. Steel just got a little stranger than it already was. An activist investor ...

Kirkland, Latham, Paul Weiss and others have replaced the likes of Sullivan & Cromwell, Clifford Chance and Slaughter and May ...

Hundreds of energy workers in Houston have been laid off in consolidations, but the job market still looks optimistic.

UK-based global advertising powerhouse WPP is reportedly considering placing its main focus on growth in the US.